Article Text
Abstract
Objective More than half of concussions go unreported or are reported with delay, yet the neurobiological impact of this remains unknown. We aimed to compare post-concussion biomarkers among individuals with different concussion histories and reporting status.
Design Longitudinal cohort.
Setting Clinical.
Participants Blood samples were collected from 287 military academy cadets and collegiate athletes diagnosed with concussion in the Advanced Research arm of the Concussion Assessment, Research, and Education (CARE) Consortium.
Interventions (or Assessment of Risk Factors) We extracted each participant’s self-reported a) previous concussion diagnosis status (no history, all diagnosed, 1+ undiagnosed) and b) whether they had delayed or immediate symptom onset, symptom reporting, and/or removal from activity following the incident concussion.
Outcome Measures We compared the following neural injury blood biomarkers between previous concussion diagnosis status groups and care-seeking groups: glial fibrillary acidic protein (GFAP), ubiquitin c-terminal hydrolase-L1 (UCH-L1), neurofilament light chain (NF-L), and tau protein – captured at baseline, 24–48 hours, asymptomatic, and 7 days post-unrestricted return-to-activity using tests of parallel profiles while controlling for several covariates.
Main Results The undiagnosed prior concussion group had higher levels of NF-L at 24–48 hours (p=.02, Cohen’s D=0.30) and asymptomatic (p=.02, Cohen’s D=0.39) timepoints relative to all diagnosed or no prior concussion groups. For those not immediately removed from activity, UCH-L1 was lower at 7 days post-return-to-activity (p=.02, Cohen’s D=0.29). No other biomarker differences were observed.
Conclusions Individuals with previously undiagnosed concussions or delayed removal from activity showed some different biomarker levels post-concussion and following clinical recovery, highlighting the importance of concussion care-seeking.